Ascorbic Acid Prevents Blood–Brain Barrier Disruption and Sensory Deficit Caused by Sustained Compression of Primary Somatosensory Cortex
- 6 January 2010
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 30 (6), 1121-1136
- https://doi.org/10.1038/jcbfm.2009.277
Abstract
Transient compression of rat somatosensory cortex has been reported to affect cerebral microvasculature and sensory function simultaneously. However, the effects of long-term cortical compression remain unknown. Here, we investigated whether and to what extent sustained but moderate epidural compression of rat somatosensory cortex impairs somatic sensation and/or cortical microvasculature. Electrophysiological and behavioral tests revealed that sustained compression caused only short-term sensory deficit, particularly at 1 day after injury. Although the diameter of cortical microvessels was coincidentally reduced, no ischemic insult was observed. By measuring Evans Blue and immunoglobulin G extravasation, the blood–brain barrier (BBB) permeability was found to dramatically increase during 1 to 3 days, but this did not lead to brain edema. Furthermore, immunoblotting showed that the BBB component proteins occludin, claudin-5, type IV collagen, and glial fibrillary acidic protein were markedly upregulated in the injured cortex during 1 to 2 weeks when BBB regained integrity. Conversely, treatment of ascorbic acid prevented compression-induced BBB disruption and sensory impairment. Together, these data suggest that sustained compression of the somatosensory cortex compromises BBB integrity and somatic sensation only in the early period. Ascorbic acid may be used therapeutically to modulate cortical compression and/or BBB dysfunction.This publication has 40 references indexed in Scilit:
- Fluvastatin stabilizes the blood–brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chainsNeuropharmacology, 2006
- Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformationsNeuroscience, 2006
- Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in miceJournal of Cell Science, 2006
- Cyclic Strain–Mediated Regulation of Vascular Endothelial Occludin and ZO-1Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Astrocyte–endothelial interactions at the blood–brain barrierNature Reviews Neuroscience, 2006
- A possible role for humoral immunity in the pathogenesis of Parkinson's diseaseBrain, 2005
- Treatment of intracerebral haemorrhageThe Lancet Neurology, 2005
- Activation–flow coupling during graded cerebral ischemiaBrain Research, 2005
- Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood–brain barrierExperimental Neurology, 2004
- The Effects of Decompression and Exogenous NGF on Compressed Cerebral CortexJournal of Neurotrauma, 2004